CD44 and cancer: Expression results also showed that castration-rebound VCaP-NURR1 tumors expressed enhanced levels of phenotypic markers of EMT (reduced E-cadherin and increased vimentin levels) and cancer stemness (increased CD44 and Oct4a, and decreased CD24 levels) (Fig. 5C).